State of Art of Molecular Imaging in the Diagnosis and Treatment of Dementia

Jacob Dubroff,Derek Johnson,Hugo Botha

DOI: https://doi.org/10.1016/j.jagp.2024.01.095

2024-04-01

Abstract:Molecular imaging plays a crucial role in diagnosing various types of dementias. Newly FDA-approved imaging biomarkers continue to find their place in the clinic, enhancing diagnosis and clinical management. Additionally, novel disease-modifying therapies have very recently been FDA approved. Three amyloid imaging PET probes and one tau PET probe, as well as two agents—one PET and one SPECT–evaluating the dopaminergic system/nigrostriatal degeneration are setting the stage for a new biological paradigm of dementia. Molecular imaging techniques provide valuable insights into the underlying pathological changes in the brain, allowing for earlier and more accurate diagnosis, as well as aiding in the development of targeted treatments and treatment response evaluation. Key molecular imaging tools include: 1. Positron Emission Tomography (PET) Scan: PET scans are commonly used in dementia research and clinical practice. PET scans use radiotracers that can target biomarkers associated with dementia, such as amyloid-beta and tau proteins. The accumulation of these proteins in the brain is a hallmark of Alzheimer's disease. PET scans can visualize and measure the presence and distribution of these abnormal proteins, helping in the early detection and differentiation of various dementia subtypes. 2. Single-Photon Emission Computed Tomography (SPECT): SPECT imaging, another nuclear medicine technique, uses radiotracers to study cerebral blood flow and dopamine transporter activity. It can help differentiate between different types of dementia based on characteristic patterns of regional brain activity as well as preservation or loss of dopamine transporter activity. 3. Magnetic Resonance Imaging (MRI): While MRI is not a molecular imaging technique per se, advanced MRI sequences, such as diffusion-weighted imaging (DWI) and functional MRI (fMRI), can provide valuable information about the structural and functional changes associated with dementia. These changes can aid in the early diagnosis and monitoring of disease progression. MRI is an essential tool in the overall work-up of Dementias and an integral part in the new ATN paradigm.

psychiatry,geriatrics & gerontology,gerontology